Caltech Researcher Helps Develop Technique That Homes In On Aggressive, Difficult-To-Treat HER2+ Breast Cancer Cells

News — By on April 1, 2009 at 1:00 am

Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, says a team of researchers from the California Institute of Technology (Caltech), the Israel Institute of Technology (Technion) and the Cedars-Sinai Medical Center.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback